$22.00
Manufacturer: Ukraine
Purpose: Antibiotic inhibiting bacterial protein synthesis for infections.
Description
Azimed (azithromycin) Coated Tablets 0.5 g. N3
Ingredients
Each coated tablet contains 0.5 g of azithromycin.
Dosage
The usual dose is one tablet (0.5 g) once a day. It is important to follow the dosage instructions provided by your healthcare provider.
Indications
Azimed tablets are indicated for the treatment of bacterial infections. These infections may include respiratory tract infections, skin and soft tissue infections, and sexually transmitted diseases.
Contraindications
Do not take Azimed if you are allergic to azithromycin or any other macrolide antibiotics. It is important to inform your doctor about any allergies before starting this medication.
Directions
Swallow the tablet whole with a full glass of water. It can be taken with or without food. Do not crush or chew the tablet.
Scientific Evidence
Azithromycin, the active ingredient in Azimed tablets, has been extensively studied for its efficacy in treating various bacterial infections. Research published in the Journal of Antimicrobial Chemotherapy has shown that azithromycin is effective against a wide range of pathogens, making it a valuable antibiotic in clinical practice.
Additional Information
Azimed tablets are coated for easier swallowing and improved absorption in the body. It is important to complete the full course of treatment as prescribed by your healthcare provider to ensure the infection is fully treated.
Pharmacological Effects: Azithromycin works by inhibiting bacterial protein synthesis, leading to the disruption of bacterial growth and reproduction. This mechanism of action makes it effective against various bacterial strains.
Clinical Trials: Clinical trials have demonstrated the efficacy of azithromycin in treating respiratory infections, skin infections, and other bacterial conditions. A study published in the International Journal of Infectious Diseases found that azithromycin was as effective as other antibiotics in treating community-acquired pneumonia.
Recent Reviews